AptarGroup upgraded by Jefferies with a new price target

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been named one of Barron's 100 Most Sustainable U.S. Companies for the seventh consecutive year and is ranked number 26 out of the top 100 companies for 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250327061242/en/Graphic: Aptar Named One of Barron's 100 Most Sustainable U.S. Companies for the Seventh Consecutive Year. Used with permission. ©2025 Dow Jones & Company, Inc. "Being recognized as one of Barron's most sustainable companies for seven consecutive years is a true honor and a reflection of

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been recognized for its leadership on climate change topics by the global environmental non-profit CDP, securing a place on its prestigious "A List." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250320115749/en/Graphic: Aptar Recognized with Prestigious ‘A' Score on the CDP Climate Change Assessment Aptar was recognized for its actions to cut emissions, mitigate climate risks and further the low-carbon economy, based on the data reported by the Company through CDP's 2024 corporate questionnaire. In 2024,

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong fourth quarter results due to solid operational performance driven by top and bottom line improvements. Results were driven by sales growth in pharma solutions, increased demand for closures technologies and productivity gains across the company. Reported sales increased by 1% and core sales increased by 2% due to a negative currency effect. Aptar reported net income of $101 million for the quarter, a 62% increase from the prior year. In addition, the quarterly results benefited from a lower effective tax rate. This press release features multimedi

Raymond James initiated coverage of AptarGroup with a rating of Outperform and set a new price target of $200.00

BofA Securities downgraded AptarGroup from Buy to Neutral and set a new price target of $173.00

Jefferies upgraded AptarGroup from Hold to Buy and set a new price target of $215.00 from $155.00 previously

4 - APTARGROUP, INC. (0000896622) (Issuer)

4 - APTARGROUP, INC. (0000896622) (Issuer)

4 - APTARGROUP, INC. (0000896622) (Issuer)

DEFA14A - APTARGROUP, INC. (0000896622) (Filer)

DEF 14A - APTARGROUP, INC. (0000896622) (Filer)

10-K - APTARGROUP, INC. (0000896622) (Filer)

Aptar Names Vanessa Kanu, A Finance Veteran with Over 25 Years of Experience, as Next CFO AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Bob Kuhn, Executive Vice President and Chief Financial Officer (CFO) since 2008, has decided to retire at the end of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725873916/en/(Left to right) Bob Kuhn, Executive Vice President and Chief Financial Officer since 2008, has decided to retire at the end of 2024; Vanessa Kanu will become Executive Vice President and CFO on January 1, 2025,

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905451175/en/Sarah Glickman Joins Aptar's Board of Directors (Photo: Aptar) "We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah's extensive knowledge of all aspects of corporate finance coupled with her global operational experience, including in the pharmaceutical industry

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that Julie Xing has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230220005172/en/Julie Xing Joins Aptar's Board of Directors (Photo: Aptar) With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie's leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. With her solid track record of business transformation in multiple g

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong fourth quarter results due to solid operational performance driven by top and bottom line improvements. Results were driven by sales growth in pharma solutions, increased demand for closures technologies and productivity gains across the company. Reported sales increased by 1% and core sales increased by 2% due to a negative currency effect. Aptar reported net income of $101 million for the quarter, a 62% increase from the prior year. In addition, the quarterly results benefited from a lower effective tax rate. This press release features multimedi

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.45 per share. The payment date is February 26, 2025, to stockholders of record as of February 5, 2025. As previously announced, Aptar will hold a conference call on Friday, February 7, 2025 at 8:00 a.m. Central Time to discuss the Company's fourth quarter and year-end results for 2024. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases. Quarterly Conference Calls   Press Release (1) Conference Call (2) 4th Quarter and Annual 2024 Results February 6, 2025 February 7, 2025, at 8:00 a.m. CT 1st Quarter 2025 Results May 1, 2025 May 2, 2025, at 8:00 a.m. CT 2nd Quarter 2025 Results July 31, 2025 August 1, 2025, at 8:00 a.m. CT 3rd Quarter 2025

SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)